CLINICAL TRIALS PROFILE FOR BRINEURA
✉ Email this page to a colleague
All Clinical Trials for BRINEURA
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT05152914 ↗ | Intravitreal ERT to Prevent Retinal Disease Progression in Children With CLN2 | Enrolling by invitation | David L Rogers, MD | Phase 1/Phase 2 | 2021-11-01 | This is a phase I/II randomized, masked, clinical trial to determine the safety and efficacy of intravitreal administration of cerliponase alfa. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for BRINEURA
Condition Name
Clinical Trial Locations for BRINEURA
Trials by Country
Clinical Trial Progress for BRINEURA
Clinical Trial Phase
Clinical Trial Sponsors for BRINEURA
Sponsor Name